Evidence map›Paper›PMID 26567509›Full record

ArticleCell host & microbe2015

CDK11 in TREX/THOC Regulates HIV mRNA 3' End Processing.

Vladimir Pak, Tristan T Eifler, Stefanie Jäger, Nevan J Krogan, Koh Fujinaga, B Matija Peterlin

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. CMGC Kinases in Viral Infection and Human Disease.Pathogens (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Cyclin-dependent kinases: Masters of the eukaryotic universe.Wiley interdisciplinary reviews. RNA · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Structure and activation mechanism of the yeast RNA Pol II CTD kinase CTDK-1 complex.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vladimir PakDepartments of Medicine, Microbiology, and Immunology, University of California at San Francisco, San Francisco, CA 94143, USA.
Tristan T EiflerDepartments of Medicine, Microbiology, and Immunology, University of California at San Francisco, San Francisco, CA 94143, USA.
Stefanie JägerDepartment of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, CA 94143, USA; Gladstone Institutes, San Francisco, CA, 94143, USA.
Nevan J KroganDepartment of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, CA 94143, USA; Gladstone Institutes, San Francisco, CA, 94143, USA.
Koh FujinagaDepartments of Medicine, Microbiology, and Immunology, University of California at San Francisco, San Francisco, CA 94143, USA.
B Matija PeterlinDepartments of Medicine, Microbiology, and Immunology, University of California at San Francisco, San Francisco, CA 94143, USA. Electronic address: matija.peterlin@ucsf.edu.
University of California, San Francisco · USGladstone Institutes · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRANKEL, ALAN D · 2007 to 2018
$48.8M
Molecular Virology and Systems Biology Screening CoreP01AI090935 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HOFFMANN, ALEXANDER · 2010 to 2014
$20.4M
Rewiring Therapeutic Cells: User-Controlled T Cells and Stem CellsP50GM081879 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIM, WENDELL A · 2010 to 2017
$19.0M
Roles of N-TEF and P-TEBb in HIV LatencyP01AI058708 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI PETERLIN, BORIS MATIJA · 2004 to 2009
$11.6M
TAT TransactivationR01AI049104 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETERLIN, BORIS MATIJA · 2001 to 2015
$5.3M
TAT TransactivationR01AI125104 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETERLIN, BORIS MATIJA · 2016 to 2020
$2.0M
NIAID NIH HHS AI076113NIAID NIH HHS P01 AI058708NIAID NIH HHS P01 AI090935NIAID NIH HHS P01AI090935NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI049104NIAID NIH HHS R01 AI125104NIAID NIH HHS U19AI076113NIGMS NIH HHS P50 GM081879NIGMS NIH HHS P50 GM082250
6 · The paper itself

Abstract

Transcriptional cyclin-dependent kinases play important roles in eukaryotic gene expression. CDK7, CDK9 (P-TEFb), and CDK13 are also critical for HIV replication. However, the function of CDK11 remained enigmatic. In this report, we determined that CDK11 regulates the cleavage and polyadenylation (CPA) of all viral transcripts. CDK11 was found associated with the TREX/THOC, which recruited this kinase to DNA. Once at the viral genome, CDK11 phosphorylated serines at position 2 in the CTD of RNAPII, which increased levels of CPA factors at the HIV 3' end. In its absence, cleavage of viral transcripts was greatly attenuated. In contrast, higher levels of CDK11 increased the length of HIV poly(A) tails and the stability of mature viral transcripts. We conclude that CDK11 plays a critical role for the cotranscriptional processing of all HIV mRNA species.

Indexed as

RNA 3' End ProcessingCell Cycle ProteinsCyclin-Dependent KinasesDNA-Binding ProteinsExodeoxyribonucleasesHEK293 CellsHeLa CellsHIVHumansJurkat CellsNuclear ProteinsPhosphoproteinsPhosphorylationPolyadenylationRNA-Binding ProteinsCDK11a protein, humanCell Cycle ProteinsCyclin-Dependent KinasesDNA-Binding ProteinsExodeoxyribonucleasesNuclear ProteinsPhosphoproteinsRNA-Binding ProteinsTHOC1 protein, humanthree prime repair exonuclease 1

Identifiers

PMID26567509
PMCPMC4648707
OpenAlexW2141221980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.